Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Rukiye Arikan"'
Autor:
Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Muhammed Mustafa Atci, Atakan Topçu, Gökhan Uçar, Baran Akagündüz, Musa Bariş Aykan, Miraç Özen, Naziyet Köse Baytemur, Melike Özçelik, Elif Şahin, Denizcan Güven, Serkan Menekşe, Naziye Ak, Fatih Teker, Engin Kut, Teoman Şakalar, Özkan Alan, Turgut Kaçan, Nazim Serdar Turhal, Saadettin Kiliçkap, Sema Türker, Mehmet Ali Nahit Şendur, Osman Köstek, Mustafa Karaağaç, Abdullah Sakin, Haci Mehmet Türk, Dilek Çağlayan, Şener Cihan, Yusuf Açikgöz, Doğan Uncu
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 5 (2022)
Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of HER2-positive metastatic gastric adenocarcinoma. However, there is no comprehensive study on which platinum-based treatment should be preferred.
Externí odkaz:
https://doaj.org/article/76c42bc31695447ca49b70652deb5b62
Autor:
Ozkan Alan, Tugba Akin Telli, Bilge Aktas, Sinan Koca, Ilker Nihat Ökten, Rahib Hasanov, Tugba Basoglu, Rukiye Arikan, Nazim Can Demircan, Ozlem Ercelep, Serap Kaya, Mustafa Umit Ugurlu, Handan Kaya, Nalan Akgul Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Purpose Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall surviv
Externí odkaz:
https://doaj.org/article/9854984b8d9e4981ac56e556ec7b4c9c
Autor:
Rukiye Arikan, Salih Ozguven, Tugba Akin Telli, Selver Isik, Nazım Can Demircan, Tugba Basoglu, Alper Yasar, Abdussamet Celebi, Nuh Filizoglu, Hilal Sagiroglu Ustun, Ilker Tinay, Tunc Ones, Halil Turgut Turoglu, Tanju Yusuf Erdil, Mehmet Akif Ozturk, Ozlem Ercelep, Vedat Bayoglu, Osman Kostek, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Acta Radiologica. 64:2040-2049
Background Prognostic markers in metastatic renal cell cancer (mRCC) are still insufficient. Any prognostic model objectively determines disease burden. Purpose To investigate the relationship between 18-fluorodeoxyglucose (18F-FDG) positron emission
Autor:
Tugba Akin Telli, Salih Ozguven, Ozkan Alan, Nuh Filizoglu, Mehmet Akif Ozturk, Nisanur Sariyar, Selver Isik, Rukiye Arikan, Nazim Can Demircan, Tugba Basoglu, Ilknur Alsan Cetin, Tunc Ones, Ozlem Ercelep, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Annals of Nuclear Medicine. 36:964-975
Objective We aimed to evaluate whether baseline Ga-68-PSMA PET/CT-derived whole-body volumetric parameters could be used as predictive biomarkers for survival in metastatic castration-resistant prostate cancer (mCRPC) patients receiving first-line tr
Autor:
Tugba Akin Telli, Mehmet Akif Ozturk, Ozkan Alan, Rahib Hasanov, Osman Kostek, Rukiye Arikan, Tugba Basoglu, Serap Kaya, Ozlem Ercelep, Nalan Akgul Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Future Oncology. 18:2425-2439
Breast cancer (BC) remains the most common cancer among women worldwide. Hormone receptor-positive (estrogen receptor- and/or progesterone receptor-positive) BC represents 70% of all cases. Advances in the treatment of disease lead to improved patien
Autor:
Nazım Can Demircan, Faysal Dane, Rukiye Arikan, Tanju Yusuf Erdil, Ozlem Ercelep, Perran Fulden Yumuk, Tugba Akin Telli, Osman Kostek, Handan Kaya, Hülya Şahin Özkan, Salih Ozguven, Mustafa Umit Ugurlu, Merve Çınar, Tunc Ones, Tugba Basoglu
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 41:171-178
Resumen Objetivo Investigamos la correlacion entre los indices de PET/TC con 18F-FDG y la respuesta patologica en el cancer de mama tratado con quimioterapia neoadyuvante (QNA), que se puntuo con el sistema de carga de cancer residual (RCB) despues d
Autor:
Tugba Akin Telli, Ozkan Alan, Nazim Can Demircan, Nisanur Sariyar, Rukiye Arikan, Tugba Basoglu, Alper Yasar, Abdussamet Celebi, Selver Isik, Omer Sofulu, Bulent Erol, Huseyin Kemal Turkoz, Zerrin Ozgen, Ozlem Ercelep, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Revue de Chirurgie Orthopédique et Traumatologique. 109:463-464
Autor:
Fatih Emin Öztürk, Nazım Can Demircan, Kadriye Ebru Akar, Nalan Akgul Babacan, Pelin Bagci, Tugba Akin Telli, Mehmet Akif Ozturk, Faysal Dane, Tugba Basoglu, Rukiye Arikan, Ozlem Ercelep, Perran Fulden Yumuk
Publikováno v:
Balkan Medical Journal, Vol 39, Iss 1, Pp 12-20 (2022)
Background: Pancreatic ductal adenocarcinoma differs from other solid tumors with its unique immunosuppressive microenvironment and non-immunogenic feature. There are not many studies in the literature investigating the effect of these features on pr
Initial albumin-bilirubin grade as a prognostic indicator of pancreatic cancer with liver metastasis
Autor:
Seval AY, Muhammed Mustafa ATCI, Rukiye ARIKAN, Özgecan DÜLGAR, Deniz TATAROĞLU ÖZYÜKSELER, Mahmut GÜMÜŞ
Objective: Pancreatic cancer (PCa) is the fourth leading cause of cancer-related deaths. Thus, there is a need for prognostic in-dicators that can aid in disease classification and subsequent selection of appropriate treatment options. Albumin-biliru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b027ba53287f95f3a5fb16ece9d012
https://hdl.handle.net/11424/289005
https://hdl.handle.net/11424/289005
Autor:
Muhammed Mustafa Atci, Baran Akagunduz, Metin Demir, Rukiye Arikan, Seval Ay, Muhammet Ozer, Murat Ayhan, Ibrahim Cil, Nazan Demir, Neslihan Ozyurt, Gökhan Karakaya, Gokcen Tugba Cevik, Arif Hakan Onder, Oguzhan Selvi, Abdullah Sakin
The aim of this multicentre retrospective study was to compare the efficacy of adjuvant chemotherapy regimens both with and without oxaliplatin and tumor sidedness in stage IIB (pT4aN0) colon cancer patients. This study included patients with stage I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb53b257b4234927987052f53a720d9f
https://hdl.handle.net/11424/287169
https://hdl.handle.net/11424/287169